Zobrazeno 1 - 10
of 126
pro vyhledávání: '"European society for medical oncology"'
Autor:
Louahed, Jamila, Dréno, B., Gaulis, Swann, Helleputte, Thibault, Dupont, Pierre, Gruselle, Olivier, Spatz, A., Kruit, W., Lehmann, F., Brichard, Vincent, European society for medical oncology
Publikováno v:
Annals of Oncology, Vol. 19, no. Sppl. 8, p. VIII61-VIII62 (2008)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::d872e3a75d269f3da8c5bfdc63db4688
https://hdl.handle.net/2078.1/107830
https://hdl.handle.net/2078.1/107830
At head of title: European Society for Medical Oncology.
Autor:
Ludwig, Heinz1, European Society for Medical Oncology (CORPORATE AUTHOR)
Publikováno v:
Lancet Oncology. Feb2003, Vol. 4 Issue 2, p71-72. 2p.
Autor:
Giuliani, Rosa, Tabernero, Josep, Cardoso, Fatima, McGregor, Keith Hanson, Vyas, Malvika, De Vries, Elisabeth G E, Universitat Autònoma de Barcelona. Departament de Medicina
Publikováno v:
Scientia
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
ESMO Open, Vol 4, Iss 2 (2019)
ESMO Open
ESMO Open, 4(2):000460. BMJ PUBLISHING GROUP
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
ESMO Open, Vol 4, Iss 2 (2019)
ESMO Open
ESMO Open, 4(2):000460. BMJ PUBLISHING GROUP
Biosimilars; Oncologia; Prescriptors Biosimilares; Oncología; Prescriptores Biosimilars; Oncology; Prescribers Background: Biosimilars can potentially improve the sustainability of cancer care; however, uptake is sometimes limited by safety concerns
Autor:
Strauss, S.J., Frezza, A.M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J.Y., Bolle, S., Bonvalot, S., Boukovinas, I., Bovee, J.V.M.G., Boye, K., Brennan, B., Brodowicz, T., Buonadonna, A., Alava, E. de, Tos, A.P. dei, Muro, X.G. del, Dufresne, A., Eriksson, M., Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Gaspar, N., Gasperoni, S., Gelderblom, H., Gouin, F., Grignani, G., Gronchi, A., Haas, R., Hassan, A.B., Hecker-Nolting, S., Hindi, N., Hohenberger, P., Joensuu, H., Jones, R.L., Jungels, C., Jutte, P., Kager, L., Kasper, B., Kawai, A., Kopeckova, K., Krakorova, D.A., Cesne, A. le, Grange, F. le, Legius, E., Leithner, A., Pousa, A.L., Martin-Broto, J., Merimsky, O., Messiou, C., Miah, A.B., Mir, O., Montemurro, M., Morland, B., Morosi, C., Palmerini, E., Pantaleo, M.A., Piana, R., Piperno-Neumann, S., Reichardt, P., Rutkowski, P., Safwat, A.A., Sangalli, C., Sbaraglia, M., Scheipl, S., Schoffski, P., Sleijfer, S., Strauss, D., Hall, K.S., Trama, A., Unk, M., Sande, M.A.J. van de, Graaf, W.T.A. van der, Houdt, W.J. van, Frebourg, T., Ladenstein, R., Casali, P.G., Stacchiotti, S., ESMO Guidelines Comm, EURACAN, GENTURIS, ERN PaedCan
Publikováno v:
Annals of Oncology, 32(12), 1520-1536. ELSEVIER
Strauss, S J, Frezza, A M, Abecassis, N, Bajpai, J, Bauer, S, Biagini, R, Bielack, S, Blay, J Y, Bolle, S, Bonvalot, S, Boukovinas, I, Bovee, J V M G, Boye, K, Brennan, B, Brodowicz, T, Buonadonna, A, de Álava, E, Dei Tos, A P, Garcia Del Muro, X, Dufresne, A, Eriksson, M, Fagioli, F, Fedenko, A, Ferraresi, V, Ferrari, A, Gaspar, N, Gasperoni, S, Gelderblom, H, Gouin, F, Grignani, G, Gronchi, A, Haas, R, Hassan, A B, Hecker-Nolting, S, Hindi, N, Hohenberger, P, Joensuu, H, Jones, R L, Jungels, C, Jutte, P, Kager, L, Kasper, B, Kawai, A, Kopeckova, K, Krákorová, D A, Le Cesne, A, Le Grange, F, Legius, E, Leithner, A, Safwat, A A, Sangalli, C, Sbaraglia, M, Scheipl, S, Schöffski, P, Sleijfer, S, Strauss, D, Sundby Hall, K, Trama, A, Unk, M, van de Sande, M A J, van der Graaf, W T A, Van Houdt, W, Frebourg, T, Ladenstein, R, Casali, P G, Stacchiotti, S & ESMO Guidelines Committee, EURACAN, GENTURIS and ERN PaedCan. Electronic address: clinicalguidelines@esmo.org 2021, ' Bone sarcomas : ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 32, no. 12, pp. 1520-1536 . https://doi.org/10.1016/j.annonc.2021.08.1995
Digital.CSIC. Repositorio Institucional del CSIC
instname
Annals of oncology : official journal of the European Society for Medical Oncology, 32(12), 1520-1536. Oxford University Press
Strauss, S J, Frezza, A M, Abecassis, N, Bajpai, J, Bauer, S, Biagini, R, Bielack, S, Blay, J Y, Bolle, S, Bonvalot, S, Boukovinas, I, Bovee, J V M G, Boye, K, Brennan, B, Brodowicz, T, Buonadonna, A, de Álava, E, Dei Tos, A P, Garcia Del Muro, X, Dufresne, A, Eriksson, M, Fagioli, F, Fedenko, A, Ferraresi, V, Ferrari, A, Gaspar, N, Gasperoni, S, Gelderblom, H, Gouin, F, Grignani, G, Gronchi, A, Haas, R, Hassan, A B, Hecker-Nolting, S, Hindi, N, Hohenberger, P, Joensuu, H, Jones, R L, Jungels, C, Jutte, P, Kager, L, Kasper, B, Kawai, A, Kopeckova, K, Krákorová, D A, Le Cesne, A, Le Grange, F, Legius, E, Leithner, A, Safwat, A A, Sangalli, C, Sbaraglia, M, Scheipl, S, Schöffski, P, Sleijfer, S, Strauss, D, Sundby Hall, K, Trama, A, Unk, M, van de Sande, M A J, van der Graaf, W T A, Van Houdt, W, Frebourg, T, Ladenstein, R, Casali, P G, Stacchiotti, S & ESMO Guidelines Committee, EURACAN, GENTURIS and ERN PaedCan. Electronic address: clinicalguidelines@esmo.org 2021, ' Bone sarcomas : ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 32, no. 12, pp. 1520-1536 . https://doi.org/10.1016/j.annonc.2021.08.1995
Digital.CSIC. Repositorio Institucional del CSIC
instname
Annals of oncology : official journal of the European Society for Medical Oncology, 32(12), 1520-1536. Oxford University Press
A. Kawai43, K. Kopeckova44, D. A. Krakorova45, A. Le Cesne46, F. Le Grange1, E. Legius47, A. Leithner48, A. Lopez Pousa49, J. Martin-Broto36, O. Merimsky50, C. Messiou51, A. B. Miah52, O. Mir53, M. Montemurro54, B. Morland55, C. Morosi56, E. Palmerin
Autor:
Alessio Cortellini, Gino M Dettorre, Urania Dafni, Juan Aguilar-Company, Luis Castelo-Branco, Matteo Lambertini, Spyridon Gennatas, Vasileios Angelis, Ailsa Sita-Lumsden, Jacobo Rogado, Paolo Pedrazzoli, David Viñal, Aleix Prat, Maura Rossi, Rossana Berardi, Teresa Alonso-Gordoa, Salvatore Grisanti, Georgia Dimopoulou, Paola Queirolo, Sylvain Pradervand, Alexia Bertuzzi, Mark Bower, Dirk Arnold, Ramon Salazar, Marco Tucci, Kevin J Harrington, Francesca Mazzoni, Uma Mukherjee, Zoi Tsourti, Olivier Michielin, Fanny Pommeret, Joan Brunet, Bruno Vincenzi, Giuseppe Tonini, Andrea Patriarca, Federica Biello, Marco Krengli, Josep Tabernero, George Pentheroudakis, Alessandra Gennari, Solange Peters, Emanuela Romano, David J Pinato
Publikováno v:
Scientia
BackgroundAs management and prevention strategies against COVID-19 evolve, it is still uncertain whether prior exposure to immune checkpoint inhibitors (ICIs) affects COVID-19 severity in patients with cancer.MethodsIn a joint analysis of ICI recipie